newsfilter
← Latest News
Business Wire·

DiaMedica Therapeutics to Participate in Upcoming Investor Conferences

DiaMedica Therapeutics Inc. (NASDAQ:DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction, and acute ischemic stroke, today announced that